Eric Pauwels - Jan 3, 2025 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: CHIEF EXECUTIVE OFFICER
Signature: /s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol: PTCT
Transactions as of: Jan 3, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/7/2025, 05:20 PM
Previous filing: Apr 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Award	$0	+22K	+32.1%	$0.00	90.5K	Jan 3, 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+55K		$0.00	55K	Jan 3, 2025	Common Stock	55K	$46.54	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.
F2	Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.
F3	This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.